Record Revenues in Q1 2025
Achieved record revenues of $14.6 million, representing an increase of nearly 50% year-over-year, driven by strong demand from major brand partners and successful product launches.
NASDAQ Uplisting
Solesence began trading on NASDAQ on April 8, 2025, under the ticker SLSN, expected to increase visibility, marketability, liquidity, and access to capital markets.
New Patent Achievements
Secured three new patents for Kleair technology, plant-based antioxidant technology, and skin healing technology, enhancing competitive position and global IP protection.
Strong Open Order Growth
Shipped and open orders exceeded $45 million, compared to about $40 million in Q1 2024, indicating strong future demand and growth potential.